PAR-22-136: Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.
National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on June 17, 2024.
From the official notice on Grants.gov, last changed April 11, 2022. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeK12
- Clinical trialsOptional
- Funded byNCI
- Median yearly award$737,500
- Typical project length7.5 years
- K12, Institutional Career Development Program. An institution's program that places early-career researchers in mentored career development. Other open K12 notices.
Projects funded under PAR-22-136 were run by National Cancer Institute (NCI, 16 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-22-136 in the NIH Guide.
Key dates
| Posted | April 11, 2022 |
|---|---|
| Deadline | June 17, 2024 |
| Archived by Grants.gov | July 23, 2024 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Most of the program's money (72% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scientists trained in clinical and translational cancer research, and to promote their career development as cancer researchers.
Funded under PAR-22-136 so far
NIH funded 16 projects under PAR-22-136 in fiscal 2023 to 2026, at 16 institutions. The median yearly award was $737,500.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Pediatric Oncology Career Development Program at St. Jude | St. Jude Children's Research Hospital | 2026 | $377,821 |
| Preparing Nurse Scientists to Lead the Future of Oncology Research | Roswell Park Cancer Institute Corp | 2026 | $778,025 |
| MSK Paul Calabresi Career Development Award for Clinical Oncology | Sloan-Kettering Inst Can Research | 2026 | $804,720 |
| Physician Scientist Training in Clinical Oncology | University of Pennsylvania | 2026 | $782,014 |
| Clinical Oncology Research Program (CORP) | Case Western Reserve University | 2026 | $806,941 |
| Montefiore Einstein Clinical Oncology Training Program in the Bronx | Albert Einstein College of Medicine | 2026 | $707,977 |
| Paul Calabresi Award in Clinical Oncology Research | University of Colorado Denver | 2026 | $787,233 |
| CUIMC Calabresi Clinical Oncology Career Development Program | Columbia University Health Sciences | 2026 | $895,145 |
Who has won Cancer Research Manpower grants before
From fiscal 2021 to 2025, Cancer Research Manpower (93.398) awarded $1.0 billion across 2,913 grant awards, an average of $359,612 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Sloan-Kettering Institute for Cancer Research | New York | 92 | $52.8 million |
| Dana-Farber Cancer Institute, Inc. | Massachusetts | 100 | $38.4 million |
| The Univeristy of Texas M.D. Anderson Cancer Center | Texas | 65 | $35.5 million |
| The General Hospital Corporation | Massachusetts | 58 | $35.4 million |
| The Johns Hopkins University | Maryland | 69 | $33.7 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-22-136 still open?
No. It closed on June 17, 2024.
Who can apply for Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)?
Closed June 17, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under PAR-22-136?
NIH RePORTER lists 16 projects funded under PAR-22-136 in fiscal 2023 to 2026, at 16 institutions. The most were at St. Jude Children's Research Hospital, Roswell Park Cancer Institute Corp, Sloan-Kettering Inst Can Research.
Who has won Cancer Research Manpower grants before?
The largest recipients over five fiscal years were Sloan-Kettering Institute for Cancer Research, Dana-Farber Cancer Institute, Inc., The Univeristy of Texas M.D. Anderson Cancer Center. The program made 2,913 awards worth $1.0 billion in that time.
Similar open grants
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
- R3PEATS Rigor Scholar Cohort Awards (K12)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)
- Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed)